[go: up one dir, main page]

GR3031078T3 - Antibacterial composition containing multimeric alpha-lactalbumin - Google Patents

Antibacterial composition containing multimeric alpha-lactalbumin

Info

Publication number
GR3031078T3
GR3031078T3 GR990402161T GR990402161T GR3031078T3 GR 3031078 T3 GR3031078 T3 GR 3031078T3 GR 990402161 T GR990402161 T GR 990402161T GR 990402161 T GR990402161 T GR 990402161T GR 3031078 T3 GR3031078 T3 GR 3031078T3
Authority
GR
Greece
Prior art keywords
lactalbumin
alpha
composition containing
antibacterial composition
containing multimeric
Prior art date
Application number
GR990402161T
Other languages
English (en)
Inventor
Hemant Sabharwal
Catharina Svanborg
Original Assignee
Hemant Sabharwal
Catharina Svanborg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemant Sabharwal, Catharina Svanborg filed Critical Hemant Sabharwal
Publication of GR3031078T3 publication Critical patent/GR3031078T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/24—Extraction; Separation; Purification by electrochemical means
    • C07K1/26—Electrophoresis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Electrochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
GR990402161T 1994-08-16 1999-08-26 Antibacterial composition containing multimeric alpha-lactalbumin GR3031078T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1994/000742 WO1996004929A1 (en) 1994-08-16 1994-08-16 Antibacterial composition containing multimeric alpha-lactalbumin

Publications (1)

Publication Number Publication Date
GR3031078T3 true GR3031078T3 (en) 1999-12-31

Family

ID=20393168

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402161T GR3031078T3 (en) 1994-08-16 1999-08-26 Antibacterial composition containing multimeric alpha-lactalbumin

Country Status (11)

Country Link
US (2) US6599874B1 (el)
EP (1) EP0776214B1 (el)
JP (1) JP3694319B2 (el)
AT (1) ATE182470T1 (el)
AU (1) AU7792294A (el)
CA (1) CA2197659C (el)
DE (1) DE69419782T2 (el)
DK (1) DK0776214T3 (el)
ES (1) ES2136206T3 (el)
GR (1) GR3031078T3 (el)
WO (1) WO1996004929A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
GB9724725D0 (en) * 1997-11-21 1998-01-21 Svanborg Catharina Protein production process
DE69837719T2 (de) 1997-11-21 2008-01-31 Nya Hamlet Pharma Ab Herstellungsverfahren von lactalbumin
GB9725126D0 (en) 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
JP3756449B2 (ja) * 1999-07-28 2006-03-15 森永乳業株式会社 抗潰瘍剤、抗潰瘍剤の製造方法、α−ラクトアルブミンの使用、及び潰瘍の治療方法
AU2002356112B2 (en) * 2001-08-23 2007-11-08 Westgate Biological Limited Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
CN102590413B (zh) * 2012-01-18 2013-12-25 浙江省疾病预防控制中心 一种牛α-乳白蛋白的定量检测方法
EP3295953B1 (en) 2012-08-09 2020-10-21 HAMLET Pharma AB Milk protein - fatty acid complex
AU2023357946A1 (en) 2022-10-03 2025-04-24 Linnane Pharma Ab A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment
WO2025186107A1 (en) 2024-03-04 2025-09-12 Linnane Pharma Ab Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
EP0058665B1 (en) 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
FI892006L (fi) * 1988-04-29 1989-10-30 Phil Gold Lactalbumin saosom tillaeggsaemne i mat.
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
US5795611A (en) 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
JP2961625B2 (ja) * 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法

Also Published As

Publication number Publication date
ES2136206T3 (es) 1999-11-16
CA2197659C (en) 2009-11-10
US6599874B1 (en) 2003-07-29
DE69419782D1 (de) 1999-09-02
JPH10504547A (ja) 1998-05-06
EP0776214A1 (en) 1997-06-04
US7144855B2 (en) 2006-12-05
AU7792294A (en) 1996-03-07
ATE182470T1 (de) 1999-08-15
EP0776214B1 (en) 1999-07-28
DK0776214T3 (da) 1999-11-29
DE69419782T2 (de) 1999-12-23
CA2197659A1 (en) 1996-02-22
JP3694319B2 (ja) 2005-09-14
WO1996004929A1 (en) 1996-02-22
US20040106541A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
GR3031078T3 (en) Antibacterial composition containing multimeric alpha-lactalbumin
CA2119562A1 (en) Method and compositions for the treatment of cerebral palsy
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
DE69826520D1 (en) 6-o-alkylerythromycinoxim b
IL156942A0 (en) Compounds, pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
ZA955740B (en) Anti-protozoan methods and materials
WO2000058475A3 (en) Streptococcus pneumoniae antigens
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
CA2148563A1 (en) Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
DE69739775D1 (de) Verabreichung von Produkten des 5-lipoxygenase Synthesewegs zur Behandlung von mikrobiellen Infektionen
DE3260277D1 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
GB9811347D0 (en) Improvements in or relating diagnosis and treatment of bacterial infections
Ginsburg Streptococcus.
WO2003024410A3 (en) Composition for treating streptococcus pneumoniae
WO2002000839A3 (en) Statement as to federally sponsored research
HUP9802450A3 (en) Use of prostane derivatives and the combination thereof for preparing pharmaceutical compositions for use in treatment of bacterial infections
McDougall Burns and the Use of Silver Sulphadiazine 1
Calandra Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients.
Scatizzi et al. Prevention of Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis
FR2307542A1 (fr) Nouvelle preparation immunostimulante
Meisel et al. Efficacy of ciprofloxacin in bacterial infections of the skin.
Lechi et al. Clinical evaluation of ceftazidime in the treatment of infections caused by Pseudomonas and other gram-negative bacteria.
FR2790961B1 (fr) Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales
IT1313628B1 (it) Uso di compositi di fluorochinolone contro batteri dell'apparatorespiratorio